Why the study?
Does verapamil improve cardiac function and ultrastructure in a rat model of diabetic cardiomyopathy?
Does verapamil improve cardiac function and ultrastructure in a rat model of diabetic cardiomyopathy?
Verapamil prevents diabetes-induced myocardial changes in a rat model, supporting the role of calcium overload in the pathogenesis of diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Verapamil may attenuate diabetic cardiomyopathy features in rats; leaves open calcium channel blockade as a human therapeutic target.
Afzal et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: